- Home
- HCM vs ARDT Comparison
HCM vs ARDT Comparison
Compare HCM & ARDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- ARDT
- Stock Information
- Founded
- HCM 2000
- ARDT 2001
- Country
- HCM Hong Kong
- ARDT United States
- Employees
- HCM N/A
- ARDT N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- ARDT
- Sector
- HCM Health Care
- ARDT
- Exchange
- HCM Nasdaq
- ARDT NYSE
- Market Cap
- HCM 2.3B
- ARDT 2.2B
- IPO Year
- HCM N/A
- ARDT 2024
- Fundamental
- Price
- HCM $16.11
- ARDT $13.88
- Analyst Decision
- HCM Hold
- ARDT Buy
- Analyst Count
- HCM 1
- ARDT 11
- Target Price
- HCM $19.00
- ARDT $21.55
- AVG Volume (30 Days)
- HCM 71.4K
- ARDT 277.3K
- Earning Date
- HCM 03-19-2025
- ARDT 02-26-2025
- Dividend Yield
- HCM N/A
- ARDT N/A
- EPS Growth
- HCM N/A
- ARDT N/A
- EPS
- HCM N/A
- ARDT 0.64
- Revenue
- HCM $610,806,000.00
- ARDT $5,705,817,000.00
- Revenue This Year
- HCM N/A
- ARDT $10.18
- Revenue Next Year
- HCM $15.89
- ARDT $7.77
- P/E Ratio
- HCM N/A
- ARDT $21.57
- Revenue Growth
- HCM N/A
- ARDT 11.23
- 52 Week Low
- HCM $12.84
- ARDT $13.63
- 52 Week High
- HCM $21.92
- ARDT $20.72
- Technical
- Relative Strength Index (RSI)
- HCM 68.69
- ARDT N/A
- Support Level
- HCM $13.58
- ARDT N/A
- Resistance Level
- HCM $13.96
- ARDT N/A
- Average True Range (ATR)
- HCM 0.31
- ARDT 0.00
- MACD
- HCM 0.34
- ARDT 0.00
- Stochastic Oscillator
- HCM 89.84
- ARDT 0.00
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About ARDT ARDENT HEALTH PARTNERS INC
Ardent Health Partners Inc is an operator of hospitals and a provider of healthcare services in the United States. It provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. The company has one reportable segment: healthcare services that provides healthcare services primarily through its ownership and operation of hospitals, certain of which provide related healthcare services through physician practices, outpatient centers, and post-acute facilities. Ardent has 30 acute care hospitals, more than 200 sites of care that operates across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.